Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027

1.1 Regenerative Medicine in Pharma Market Snapshot
1.2 Regenerative Medicine in Pharma Market- Key Findings

2.1 Market Definition
2.2 Market Scope and Segmentation
2.3 Industry Trends
2.3.1 HEALTHCARE TRENDS
2.3.2 REGULATORY TRENDS
2.4 Opportunities in Regenerative Medicine in Pharma
2.4.1 GENE THERAPY
2.4.2 CELL THERAPY
2.4.3 TISSUE ENGINEERED PRODUCTS AND BIOMATERIALS
2.5 Regenerative Medicines in Clinical Trials

3.1 Value Chain Analysis
3.1.1 ARM CLASSIFICATION OF REGENERATIVE MEDICINE

4.1 Differences Between Conventional Therapies and Stem Cell Therapies in Clinical Trials
4.2 US
4.2.1 REGULATORY
4.2.2 MARKET ACCESS
4.3 Europe
4.4 Regulation of Regenerative Medicine in the US and Europe
4.5 Japan
4.6 South Korea

5.1 Overview
5.1.1 LEADING CELL-BASED IMMUNOTHERAPY TREATMENTS
5.1.2 LEADING GENE THERAPY TREATMENTS
5.1.3 LEADING CELL-THERAPIES TREATMENT
5.1.4 LEADING TISSUE ENGINEERED PRODUCTS TREATMENTS

6.1 Late-Stage Gene Therapy Products
6.2 Late-Stage Gene-Modified Cell Therapy Products
6.3 Late-Stage Cell Therapy Products
6.4 Late-Stage Tissue-Engineered Treatment

7.1 Regenerative Medicine in Pharma Market Structure - PORTER’s Analysis
7.2 Deals in Regenerative Medicine in Pharma
7.3 Funding in Regenerative Medicine in Pharma

8.1 Global Digital Biomarkers Market
8.2 COVID-19 Pandemic

9.1 Regenerative Medicine in Pharma - Product Dive
9.1.1 TISSUE-ENGINEERED PRODUCTS
9.1.2 GENE THERAPIES
9.1.3 CELL THERAPIES
9.1.4 OTHERS

10.1 Regenerative Medicine in Pharma - Therapeutic Area Dive
10.1.1 ONCOLOGY
10.1.2 MUSCULOSKELETAL DISORDERS
10.1.3 IMMUNOLOGY AND INFLAMMATION
10.1.4 DERMATOLOGY
10.1.5 OTHERS

11.1 Regenerative Medicine in Pharma - Regional Deep Dive
11.1.1 NORTH AMERICA
11.1.2 EUROPE
11.1.3 ASIA-PACIFIC
11.1.4 ROW

12.1 Regenerative Medicine in Pharma - Market Trends
12.1.1 CONSTANT INNOVATION IN CELL ENGINEERING TECHNIQUES:
12.1.2 INCREASING APPLICATION OF GENE THERAPY:
12.1.3 FAST TRACK APPROVALS AND MULTIPLE DRUGS IN LAST STAGES OF PIPELINE
12.1.4 THE MOMENTUM CREATED BY ALLOGENIC THERAPEUTICS CONTINUES TO DRIVE MARKET:
12.1.5 INCREASING APPLICATIONS OF 3D PRINTING IN REGENERATIVE MEDICINE:
12.2 Regenerative Medicine in Pharma - Market Drivers
12.2.1 GROWING PREVALENCE OF CHRONIC DISEASES, GENETIC DISORDERS, AND CANCER
12.2.2 TECHNOLOGICAL ADVANCEMENTS IN STEM-CELL THERAPIES
12.2.3 INCREASED INVESTMENT BY KEY PLAYERS IN R&D OF THE REGENERATIVE MEDICINES
12.3 Regenerative Medicine in Pharma - Market Challenges
12.3.1 GENE THERAPY
12.3.2 CELL THERAPY
12.3.3 TISSUE-ENGINEERED PRODUCTS AND BIOMATERIALS

14.1 Methodology
14.2 About the Publisher

Table 1 Key Trends Overview
Table 2 Regenerative Medicine classification
Table 3 Research Scope and Segmentation
Table 4 Healthcare Trends
Table 5 Regulatory Trends
Table 6 Cell-Based Immunotherapy
Table 7 Gene Therapy
Table 8 Cell Therapies
Table 9 Tissue-Engineered Products
Table 10 Deals in Regenerative Medicine in Pharma
Table 11 Funding Activity in the Regenerative medicine in Pharma Industry
Table 12 Regenerative Medicine in Pharma Market
Table 13 Regenerative Medicine in Pharma by Product, 2020-2027 ($Mn)
Table 14 Regenerative Medicine in Pharma by Therapeutic Area, 2020-2027 ($Mn)
Table 15 Regenerative Medicine in Pharma by Region, 2020-2027 ($Mn)
Table 16 North America Regenerative Medicine in Pharma by Country, 2020-2027 ($Mn)
Table 17 Europe Regenerative Medicine in Pharma by Country, 2020-2027 ($Mn)
Table 18 Asia-Pacific Regenerative Medicine in Pharma by Country, 2020-2027 ($Mn)

Figure 1 Market Snapshot ($Mn)
Figure 2 Key Segment Performance Snapshot
Figure 3 History of Regenerative Medicine Development in 8MM
Figure 4 Clinical Trials
Figure 5 Clinical Trials by Therapy Areas
Figure 6 Regenerative Medicine in Pharma Value Chain
Figure 7 Regenerative Medicine in Pharma Value Chain
Figure 8 Regenerative Medicine in Pharma Value Chain
Figure 9 Regenerative Medicine in Pharma Value Chain
Figure 10 Regenerative Medicine Clinical Trial Model
Figure 11 Regenerative Medicine Clinical Trial Model
Figure 12 Regenerative Medicine in Pharma Value Chain
Figure 13 Marketed Regenerative Medicine by Type and Region
Figure 14 Marketed Regenerative Medicine by Therapy Area
Figure 15 Pipeline Products by Type, Phase, and Therapy Area
Figure 16 Gene Therapy Products
Figure 17 Gene-Modified Cell Therapy Products
Figure 18 Cell Therapy Products
Figure 19 Tissue-Engineered Treatment
Figure 20 Global Regenerative Medicine in Pharma PORTER’s Five Force Analysis
Figure 21 Global Regenerative medicine in Pharma Market - Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 22 Regenerative Medicine in Pharma by Product - Market Overview ($Mn)
Figure 23 Regenerative Medicine in Pharma by Product - 2021 & 2027 (%)
Figure 24 Tissue-engineered Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 25 Gene Therapies Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 26 Cell Therapies Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 27 Others Product Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 28 Regenerative Medicine in Pharma by Therapeutic Area - Market Overview ($Mn)
Figure 29 Regenerative Medicine in Pharma by Therapeutic Area - 2021 & 2027 (%)
Figure 30 Oncology Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 31 Musculoskeletal Disorders Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 32 Immunology and Inflammation Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 33 Dermatology Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 34 Others Therapeutic Area Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 35 Regenerative Medicine in Pharma by Region- Market Overview ($Mn)
Figure 36 Regenerative Medicine in Pharma by Region Share - 2021 & 2027 (%)
Figure 37 North America Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 38 Europe Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 39 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 40 ROW Market Revenue Opportunity Forecast, 2020-2027 ($Mn)